Evidence map›Paper›PMID 41618525›Full record

ArticleJournal of psychopharmacology (Oxford, England)2026

Indigenous Knowledge Systems & Psychedelic Science: Towards Ethical and Reciprocal Collaboration.

Veronica Magar, Marlena Robbins, Óscar Martín López Fernández Lobo Blanco, Ismail Lourido Ali, Brian Anderson, Charlie Grob, Jack E Henningfield, Pamela Kryskow, Heather Kuiper, Anja Loizaga-Velder and 3 more

Abstract read
In one paragraph

Article in Journal of psychopharmacology (Oxford, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Veronica MagarFormerly, Office of the Director-General, World Health Organization, Geneva, Switzerland.ORCID 0009-0001-3967-5692
Marlena RobbinsSchool of Public Health, University of California, Berkeley, California, USA.ORCID 0009-0004-0549-9637
Óscar Martín López Fernández Lobo BlancoDirector of Indigenous Peoples Coordination at Nierika Institute for Intercultural Medicine, Ocuilan, Mexico.
Ismail Lourido AliMultidisciplinary Association of Psychedelic Science (MAPS), Santa Cruz, California, USA.ORCID 0009-0001-1772-6583
Brian AndersonDepartment of Psychiatry and Behavioral Sciences, University of California, San Francisco, California, USA.ORCID 0000-0001-5023-660X
Charlie GrobDavid Geffen School of Medicine, University of California (UCLA), Los Angeles, California, USA.
Jack E HenningfieldDepartment of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.ORCID 0000-0001-8387-0041
Pamela KryskowHealth Sciences and Human Services-Vancouver Island University, Roots To Thrive Non Profit, Vancouver, British Columbia, Canada.ORCID 0000-0003-0310-0368
Heather KuiperCenter for Psychedelic Public Health, Berkeley, California, USA.ORCID 0009-0003-2882-356X
Anja Loizaga-VelderNierika Institute for Intercultural Medicine, Ocuilan, Mexico.ORCID 0000-0001-9523-3023
Brian RushInstitute for Mental Health Policy Research, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.ORCID 0000-0002-9289-6072
Miriam VolatIndigenous Medicine Conservation Fund, Santa Rosa, California, USA.ORCID 0009-0001-3445-0339
Sandor Iron RopeTiognaka Tawowakan Otokahe (TTO), South Dakota, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Indigenous Peoples have cultivated and protected natural psychoactive medicines through ceremony, kinship, and spiritual responsibility across generations, yet their long-standing contributions have often been marginalized through extractive research, commercialization, and policy exclusion. It is Indigenous communities that have stewarded and gained expertise working with psychoactive medicines for centuries, yet they remain underrepresented within the scientific discourse. This commentary advances the case for reciprocal and equitable collaboration in psychedelic science, grounded in Indigenous sovereignty, cultural and intellectual property rights, and governance. Drawing on traditions involving ayahuasca, psilocybin, peyote, and iboga, we illustrate how Indigenous methodologies, including ritual, community-based practices, and ecological approaches, offer insights critical to both safety and efficacy. We argue that research and policy must embed free, prior, and informed consent, equitable benefit-sharing, and Indigenous leadership. Such efforts require moving past tokenistic inclusion toward meaningful collaboration and systemic change in psychedelic research that is both scientifically rigorous and culturally just. We conclude by calling for more formal, transparent, and globally legitimate convening processes, such as those modeled on WHO global consultations, that can bring Indigenous leaders, researchers, and policymakers together in dialogue. These steps represent profound acts of inclusion essential for these medicines to realize their full potential to heal and transform.

Indexed as

HallucinogensBanisteriopsisCooperative BehaviorHumansHallucinogenscommunity-based researchcontemplative practicesequityimplementation scienceIndigenous governanceIndigenous Knowledge Systemspsychedelic-assisted therapypublic health policyreciprocitytraditional medicine

Identifiers

PMID41618525
PMCPMC13198619

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.